NYQ·Healthcare·$1.7B·#121 / 520 in Healthcare
AORT Artivion, Inc.
62SOLID
CATEGORY BREAKDOWN
GROWTH22
QUALITY75
STABILITY83
VALUATION81
GOVERNANCE38
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+13.6%
22
> 50% strong
Gross Margin
Revenue retained after direct costs
64.4%
92
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
57.5%
48
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.9x
81
< 3x strong
Rule of 40
Growth rate plus operating margin
20
49
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.5%
36
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+9.7%
42
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE AORT WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when AORT's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.